The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2002 3

Europe 1
United States 2

Journal Article 4

coronavirus disease 1
COVID-19 1
mathematical model 1
Paxlovid 1
public health impact 1
respiratory infections 1
SARS-CoV-2 1
SARS-CoV-2 transmission 1
severe acute respiratory syndrome coronavirus 2 1
treatment 1
viruses 1
zoonoses 1

1 - 4 of 4 Results

Refine Results

Refine Results:

The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe

CITE Title : The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe Personal Author(s) : Bronzwaer, Stef L.A.M.;Cars, Otto;Buchholz, Udo;Mölstad, Sigvard;Goettsch, Wim;Veldhuijzen, Irene K.;Kool, Jacob L.;Sprenger, Marc J.W.;Degener, John E.; Corporate Authors(s) : participants in the European Antimicrobial Resistance Surveillance System Published Date : Mar 2002 Source : Emerg Infect Dis. 8(3):278-282. URL : https://stacks.cdc.gov/view/cdc/13777 Bronzwaer, Stef L.A.M. et al. (2002). The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe. 8(3). Bronzwaer, Stef L.A.M. et al. "The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe" 8, no. 3 (2002) Bronzwaer, Stef L.A.M. et al. "The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe" vol. 8, no. 3, 2002 Export RIS Citation Information.

:

Bronzwaer, Stef L.A.M. ;

Cars, Otto

Mar 2002 | Emerg Infect Dis. 8(3):278-282.

:

In Europe, antimicrobial resistance has been monitored since 1998 by the European Antimicrobial Resistance Surveillance System (EARSS). We examined th...
Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals

CITE Title : Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals Personal Author(s) : Fridkin, Scott K.;Hill, Holly A.;Volkova, Nataliya V.;Edwards, Jonathan R.;Lawton, Rachel M.;Gaynes, Robert P.;McGowan, John E.;Hospitals, Project; Corporate Authors(s) : Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Published Date : Jul 2002 Source : Emerg Infect Dis. 8(7):697-701. URL : https://stacks.cdc.gov/view/cdc/3081 Fridkin, Scott K. et al. (2002). Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals. 8(7). Fridkin, Scott K. et al. "Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals" 8, no. 7 (2002) Fridkin, Scott K. et al. "Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals" vol. 8, no. 7, 2002 Export RIS Citation Information.

:

Fridkin, Scott K. ;

Hill, Holly A.

Jul 2002 | Emerg Infect Dis. 8(7):697-701.

:

Antimicrobial resistance is increasing in nearly all health-care-associated pathogens. We examined changes in resistance prevalence during 1996-1999 i...
Public Health Impact of Paxlovid as Treatment for COVID-19, United States

CITE Title : Public Health Impact of Paxlovid as Treatment for COVID-19, United States Personal Author(s) : Bai, Yuan;Du, Zhanwei;Wang, Lin;Lau, Eric H.Y.;Fung, Isaac Chun-Hai;Holme, Petter;Cowling, Benjamin J.;Galvani, Alison P.;Krug, Robert M.;Meyers, Lauren Ancel; Published Date : 2 2024 Source : Emerg Infect Dis. 2024; 30(2):262-269 URL : https://stacks.cdc.gov/view/cdc/147354 Bai, Yuan et al. (2024). Public Health Impact of Paxlovid as Treatment for COVID-19, United States. 30(2). Bai, Yuan et al. "Public Health Impact of Paxlovid as Treatment for COVID-19, United States" 30, no. 2 (2024) Bai, Yuan et al. "Public Health Impact of Paxlovid as Treatment for COVID-19, United States" vol. 30, no. 2, 2024 Export RIS Citation Information.

:

Bai, Yuan ;

Du, Zhanwei

2 2024 | Emerg Infect Dis. 2024; 30(2):262-269

:

We evaluated the population-level benefits of expanding treatment with the antiviral drug Paxlovid (nirmatrelvir/ritonavir) in the United States for S...
Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine

CITE Title : Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine Personal Author(s) : Marchisio, Paola;Esposito, Susanna;Schito, Gian Carlo;Marchese, Anna;Cavagna, Roberta;Principi, Nicola; Corporate Authors(s) : Hercules Project Collaborative Group Published Date : May 2002 Source : Emerg Infect Dis. 8(5):479-484. URL : https://stacks.cdc.gov/view/cdc/13792 Marchisio, Paola et al. (2002). Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine. 8(5). Marchisio, Paola et al. "Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine" 8, no. 5 (2002) Marchisio, Paola et al. "Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine" vol. 8, no. 5, 2002 Export RIS Citation Information.

:

Marchisio, Paola ;

Esposito, Susanna

May 2002 | Emerg Infect Dis. 8(5):479-484.

:

We assessed the prevalence of Streptococcus pneumoniae serotypes in the nasopharynx of healthy children, antimicrobial susceptibility patterns, risk f...